Investor Insight Silver Dollar Resources is repositioning its flagship La Joya silver-gold-copper project to unlock high-grade underground potential in Mexico’s prolific Durango-Zacatecas silver belt....
First Majestic Silver (TSX:AG,NYSE:AG) has agreed to sell its Del Toro Silver Mine in Mexico to Sierra Madre Gold and Silver (TSXV:SM,OTC:SMDRF) in a...
Turnium Technology Group Inc. (TSXV: TTGI) (FSE: E48) (‘TTGI’ or ‘the Company’), a global Technology-as-a-Service (TaaS) wholesale provider, is pleased to announce a global...
Surface Metals Inc. (CSE:SUR,OTC:SURMF) (OTCQB: SURMF) (the ‘Company’, or ‘Surface Metals’) announced today that the Company has engaged Barwicki Investor Relations to lead a...
Sister Stephanie Schmidt had a hunch about what her fellow nuns would discuss over dinner at their Erie, Pennsylvania, monastery on Wednesday night. The...
Investor Insight With a sharp focus on discovery, de-risking and resource growth, NevGold presents a compelling investment opportunity as an undervalued gold and critical...
Homerun Resources Inc. (TSXV: HMR,OTC:HMRFF) (OTCQB: HMRFF) (‘Homerun’ or the ‘Company’) is pleased to announce that Homerun Energy SRL, a 100% owned subsidiary of Homerun Resources has...
Perth, Australia (ABN Newswire) – Locksley Resources Ltd (ASX:LKY,OTC:LKYRF) (FRA:X5L) (OTCMKTS:LKYRF) is pleased to advise that the Company is advancing a significant expansion to...
On Thursday (September 11), Canadian Prime Minister Mark Carney revealed the first tranche of projects selected by the newly created Major Projects Office. The...
Gold’s record-setting price run continued this week, with yet another new all-time high in the books. Silver also fared well, breaking US$42 per ounce....
(TheNewswire) VANCOUVER September 12, 2025 TheNewswire – Providence Gold Mines Inc. (‘Providence’ or the ‘Company’) is pleased to announce a non brokered Unit Private...
Investor Insight Cardiol Therapeutics is positioned with a late-stage lead asset, multiple orphan indications, strong clinical proof-of-concept data, and a differentiated non-immunosuppressive approach to...
Investor Insight Cardiol Therapeutics is positioned with a late-stage lead asset, multiple orphan indications, strong clinical proof-of-concept data, and a differentiated non-immunosuppressive approach to...